Corporate card for ambulatory surgical centers: Why implant spend is so hard to control

Surgical preference cards, lot-tracked implants, and a dozen supply vendors make ASC spend hard to control after the fact. The right corporate card controls it before the swipe.

An ambulatory surgical center (ASC) needs a card that issues limits by vendor and provider, not just by employee. A single spine or joint surgeon can represent $200,000 to $500,000 in annual implant spend with almost no price discipline applied to it.

The spread between what two surgeons pay for a functionally identical implant can run 30% to 40%, according to Becker's ASC. A card built for that reality locks spend to the right vendor and surgeon before the purchase clears, not after the monthly statement arrives.

Why ASC spend is harder to control than a typical practice's

You run higher-stakes, higher-volume purchasing than a standard physician office, and the numbers back that up. Surgical preference cards routinely include supplies that never get used: industry research puts unused items at close to 40% of what's listed on a typical surgical preference card, according to SupplyLasso. Unnecessary surgical supply waste overall runs 15% to 25% of total supply spend.

That waste compounds because you likely accumulate vendors one relationship at a time, without ever auditing the full vendor list against volume or price. Multi-vendor management gets harder every time a new supplier gets added without review. Add FDA lot-tracking requirements on implants—units that typically run $300 to $2,000 or more each—and manual reconciliation becomes a full-time job for whoever runs your business office.

What implant vendor sprawl actually costs an ASC

Run the math on a single spine surgeon doing 150 cases a year at an average implant cost of $2,500 per case. That's $375,000 in annual implant spend from one provider. At a conservative 15% supply waste rate, $56,000 of that never should have been purchased in the first place.

Multiply that across every surgeon operating at your center and the number gets large fast, but it rarely shows up as a single line item. It's spread across dozens of vendor invoices a month, which is exactly why it survives a standard month-end review. Catching it requires controls at the point of purchase, not a retrospective audit of invoices that have already been paid.

What a corporate card needs to do for implant and supply spend

Card-level limits by vendor and provider. Ramp lets you issue cards by provider, location, or vendor category and enforce controls on every swipe. A virtual card scoped to a single implant distributor with a monthly cap catches overspend at the point of purchase—the same logic behind any strong spend control setup.

Receipt and packing-slip capture at the point of purchase. Your business office shouldn't chase surgeons or scrub techs for documentation on a $1,500 implant 3 weeks after the case. Ramp captures receipts via SMS or mobile at the point of purchase and matches each one to the transaction, location, and cost center automatically.

Vendor invoice processing that catches duplicates before they clear. Ramp's Bill Pay extracts line items, payment terms, and amounts from vendor invoices, flags duplicate invoices across 60 fraud signals, and routes approvals by location manager or practice administrator. Invoice fraud risk rises with vendor count, which an ASC accumulates fast.

A single view of vendor spend across the center. Ramp's dashboards show spend rolling up by location, provider, and vendor in real time—the kind of enterprise-wide spend visibility larger healthcare organizations already expect.

Implant vendor management: the workflow

Setting up vendor-scoped virtual cards

Start with your top five vendors by dollar volume, not your full vendor list. For each, set a monthly cap based on trailing 12-month spend plus a growth buffer, and assign the card to the specific surgeon or department driving that relationship. Review caps quarterly against actual case volume—a static limit set once and forgotten defeats the purpose of card-level control.

Writing a spend policy that respects surgeon preference

Surgeons choose implants based on clinical judgment, so a workable policy sets the vendor and price ceiling within which that choice happens, not the implant itself. That's the same logic as any well-built expense policy: clear rules, enforced automatically, with an easy path for legitimate exceptions. State which vendors are pre-approved per implant category, what triggers a review, and who approves an exception—then enforce the vendor list through the card itself.

How this compares to procurement-heavy alternatives

Procurement platforms built around three-way PO matching work well for centers with a dedicated purchasing function. Ramp's card-first approach fits centers that want controls enforced the moment a provider or vendor swipes, with Ramp Procurement available as an added layer once your center standardizes formal purchase requests. Vendor management tools layer on top of either approach once your vendor list needs centralized due diligence.

Get implant and supply spend under control before the swipe

Every number in this piece—the 30% to 40% price spread between surgeons, the $56,000 a single surgeon's caseload can leak—comes down to spend that isn't controlled until after it's already happened. Ramp fixes that by putting the limit on the card itself, before the purchase clears.

Set up a corporate card scoped to your top implant vendors, or see how Ramp for Healthcare covers the rest of your center's spend.